bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Material and Methods from Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity
Authors: Finnberg Niklas K. , Gokare Prashanth , Navaraj Arunasalam , Lang Kuhs Krystle A. , Cerniglia George , Yagita Hideo , Takeda Kazuyoshi , Motoyama Noboru , El-Deiry Wafik S.
Published: March 2023

Supplemental Material & Methods
Supplementary figure 2 from p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem–like Features via miR-885-5p Control
Authors: Meier Claudia , Hardtstock Philip , Joost Sophie , Alla Vijay , Pützer Brigitte M.
Published: March 2023

Mutual regulation of miR-885-5p by p73/DNp73.
Supplementary Figure Legends from p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem–like Features via miR-885-5p Control
Authors: Meier Claudia , Hardtstock Philip , Joost Sophie , Alla Vijay , Pützer Brigitte M.
Published: March 2023

Legends for supplementary figures S1, S2, and S3.
Supplementary Table S11 from Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers
Authors: Kaczkowski Bogumil , Tanaka Yuji , Kawaji Hideya , Sandelin Albin , Andersson Robin , Itoh Masayoshi , Lassmann Timo , Hayashizaki Yoshihide , Carninci Piero , Forrest Alistair R.R.
Published: March 2023

Summary of the enhancerRNAs detected as differentially expressed in the FANTOM5 analysis and those associated with transcript models from miTranscriptome.
Supplementary Movie 1 from Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach
Authors: Benzekry Sebastien , Tracz Amanda , Mastri Michalis , Corbelli Ryan , Barbolosi Dominique , Ebos John M.L.
Published: March 2023

Supplementary Movie 1: Primary tumor (PT) was assumed to be detected when reaching the size of 4.32 cm in diameter. Post-diagnosis PT growth and development of metastases in the case of no surgical intervention are indicated as dashed line in the left plot and white bars in the histogram on the right, respectively.
Supplementary Figure 5 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Authors: Adams Brian D. , Wali Vikram B. , Cheng Christopher J. , Inukai Sachi , Booth Carmen J. , Agarwal Seema , Rimm David L. , Győrffy Balázs , Santarpia Libero , Pusztai Lajos , Saltzman W. Mark , Slack Frank J.
Published: March 2023

Figure S5, Related to Figure 6. A, Assessment of SRC mRNA levels in MDA-MB-231 SRC-ORF, EMPTY-ORF, or parental cell lines. Data is normalized in RPL19 levels. B, Crystal violet staining assays on day 5 post-transfection confirms the ability of c-SRC to rescue miR-34a-induced anti-tumor growth. C-D, Examples of Pearson correlation analysis indicating MDA-MB-231 cells were not similar to BT-549 and MDA-MB-436 cells, and therefore were not included in the initial K-Means clustering analysis (results shown in D). E, The fold knockdown by miR-34a as compared to the miR-Scr treatments of the indicated genes in Clusters 1-3 in both BT-549 and MDA-MB-436 cells using a 2-fold change cut-off. None of the genes in Cluster 4 were downregulated by miR-34a (data not shown). F, Schematic of the KEGG pathway (hsa04510: Focal Adhesion) with miR-34a downregulated genes highlighted in red. G-H, Represents further analysis of the miR-34a gene signature in breast cancer. G, Indicates correlation analyses of miR-34a target genes in TNBC patients from Metabric data. H, Confirmation of prognostic importance of mIR-34a gene signature using a PROGgeneV2 algorithm on the TCGA data set.
Supplementary Table S2 from Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer
Authors: Ando Mizuo , Kawazu Masahito , Ueno Toshihide , Koinuma Daizo , Ando Koji , Koya Junji , Kataoka Keisuke , Yasuda Takahiko , Yamaguchi Hiroyuki , Fukumura Kazutaka , Yamato Azusa , Soda Manabu , Sai Eirin , Yamashita Yoshihiro , Asakage Takahiro , Miyazaki Yasushi , Kurokawa Mineo , Miyazono Kohei , Nimer Stephen D. , Yamasoba Tatsuya , Mano Hiroyuki
Published: March 2023

Enriched GO terms for genes adjacent to ELF4 binding regions
Supplementary Figure S7 from STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs
Authors: Walch-Rückheim Barbara , Pahne-Zeppenfeld Jennifer , Fischbach Jil , Wickenhauser Claudia , Horn Lars Christian , Tharun Lars , Büttner Reinhard , Mallmann Peter , Stern Peter , Kim Yoo-Jin , Bohle Rainer Maria , Rübe Christian , Ströder Russalina , Juhasz-Böss Ingolf , Solomayer Erich-Franz , Smola Sigrun
Published: March 2023

1.5 x 105 HeLa cells/6-well were either left untransfected or were transfected with (A) 0 µg, 0.025 µg or 0.1 µg of pCMV-Flag2-IRF1 or (B) 0 µg, 0.6 µg or 0.8 µg of pCMV-Flag2-IRF2.
Supplementary Figure S1 from Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer
Authors: Ando Mizuo , Kawazu Masahito , Ueno Toshihide , Koinuma Daizo , Ando Koji , Koya Junji , Kataoka Keisuke , Yasuda Takahiko , Yamaguchi Hiroyuki , Fukumura Kazutaka , Yamato Azusa , Soda Manabu , Sai Eirin , Yamashita Yoshihiro , Asakage Takahiro , Miyazaki Yasushi , Kurokawa Mineo , Miyazono Kohei , Nimer Stephen D. , Yamasoba Tatsuya , Mano Hiroyuki
Published: March 2023

Expression level of ELF4 in trasient transfection assays
Supplementary methods from STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
Authors: Koyama Shohei , Akbay Esra A. , Li Yvonne Y. , Aref Amir R. , Skoulidis Ferdinandos , Herter-Sprie Grit S. , Buczkowski Kevin A. , Liu Yan , Awad Mark M. , Denning Warren L. , Diao Lixia , Wang Jing , Parra-Cuentas Edwin R. , Wistuba Ignacio I. , Soucheray Margaret , Thai Tran , Asahina Hajime , Kitajima Shunsuke , Altabef Abigail , Cavanaugh Jillian D. , Rhee Kevin , Gao Peng , Zhang Haikuo , Fecci Peter E. , Shimamura Takeshi , Hellmann Matthew D. , Heymach John V. , Hodi F. Stephen , Freeman Gordon J. , Barbie David A. , Dranoff Glenn , Hammerman Peter S. , Wong Kwok-Kin
Published: March 2023

This file contains detailed information about the methods in the manuscript. These include: a list of clone names for all the antibodies, gating method for FACS analysis and sorting, method for mouse RNA sequencing data analysis and human gene expression and proteomic data analysis (CCLE, TCGA and PROSPECT), method for cytokine/chemokine analysis from BAL fluid and culture media.
Supplemental Figure Legends from EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
Authors: Lim Seung-Oe , Li Chia-Wei , Xia Weiya , Lee Heng-Huan , Chang Shih-Shin , Shen Jia , Hsu Jennifer L. , Raftery Daniel , Djukovic Danijel , Gu Haiwei , Chang Wei-Chao , Wang Hung-Ling , Chen Mong-Liang , Huo Longfei , Chen Chung-Hsuan , Wu Yun , Sahin Aysegul , Hanash Samir M. , Hortobagyi Gabriel N. , Hung Mien-Chie
Published: March 2023

Supplementary Figure S1. EGF signaling enhances aerobic glycolysis in TNBC cells. Supplementary Figure S2. PKM2 is a novel binding partner of EGFR and its activity is inhibited by EGFR via Tyr phosphorylation. Supplementary Figure S3. EGFR reprograms cancer cell metabolism by PKM2 phosphorylation in TNBC cells. Supplementary Figure S4. Upregulation of HK2 expression by EGF signaling also contributes to aerobic glycolysis in TNBC cells. Supplementary Figure S5. Glycolysis metabolite, F1,6BP, binds directly to and enhances the activity of EGFR. Supplementary Figure S6. The combination of EGFR and glycolysis inhibitors synergistically suppresses TNBC cell proliferation. Supplementary Figure S7. EGF signaling-induced lactate inhibits cytotoxic T cell activity in TNBC cells.
Supplementary Figures 1-6 from Peptide–Drug Conjugate GnRH–Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth
Authors: Argyros Orestis , Karampelas Theodoros , Asvos Xenophon , Varela Aimilia , Sayyad Nisar , Papakyriakou Athanasios , Davos Constantinos H. , Tzakos Andreas G. , Fokas Demosthenes , Tamvakopoulos Constantin
Published: March 2023

Supplementary Figures 1-6. Figure S.I.1 - 1HNMR spectra of the six sunitinib analogues Figure S.I.2 - LC-MS/MS characterization of SAN1 Figure S.I.3 - Molecular models of VEGFR-2 kinase domain complexed with SAN1,2,3 Figure S.I.4 - Synthesis and characterization of SAN1GSC by NMR and LC-MS/MS Figure S.I.5 - Body weights of xenografted mice during the course of treatment Figure S.I.6 - Evaluation of the hematological toxicities following treatment
Supplementary Figure Legends from Peptide–Drug Conjugate GnRH–Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth
Authors: Argyros Orestis , Karampelas Theodoros , Asvos Xenophon , Varela Aimilia , Sayyad Nisar , Papakyriakou Athanasios , Davos Constantinos H. , Tzakos Andreas G. , Fokas Demosthenes , Tamvakopoulos Constantin
Published: March 2023

Supplementary figure legends for supplementary figures 1-6
Supplemental Figure 3 from Dietary Microbes Modulate Transgenerational Cancer Risk
Authors: Poutahidis Theofilos , Varian Bernard J. , Levkovich Tatiana , Lakritz Jessica R. , Mirabal Sheyla , Kwok Caitlin , Ibrahim Yassin M. , Kearney Sean M. , Chatzigiagkos Antonis , Alm Eric J. , Erdman Susan E.
Published: March 2023

L. reuteri dietary enrichment protects the F1 progeny of NWD-fed mothers from transgenerational cancer. Pulmonary adenocarcinoma, hepatocellular carcinoma and mesenteric lymph node lymphoma in the children of mothers consuming NWD are shown in the left column. Compare with normal lung, liver and mesenteric lymph node histology from mice of similar descend that were also treated with L. reuteri.
Supplemental Figure 2 from Dietary Microbes Modulate Transgenerational Cancer Risk
Authors: Poutahidis Theofilos , Varian Bernard J. , Levkovich Tatiana , Lakritz Jessica R. , Mirabal Sheyla , Kwok Caitlin , Ibrahim Yassin M. , Kearney Sean M. , Chatzigiagkos Antonis , Alm Eric J. , Erdman Susan E.
Published: March 2023

Control and NWD-treated mice cluster separately by microbiota. NWD-treated mice carry fewer Bacteroidetes in general than their control diet-fed counterparts. Overall, there is a shift towards higher abundance of OTUs from the Firmicutes phyla and decrease in OTUs from the Bacteroidetes phyla in mice treated with NWD. These data are consistent with previous findings of elevation of Firmicutes to Bacteroidetes phyla in obese mice.
Supplementary Materials and Methods, Legends for Supplementary Figures from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
Authors: Hirata Hidenari , Sugimachi Keishi , Komatsu Hisateru , Ueda Masami , Masuda Takaaki , Uchi Ryutaro , Sakimura Shotaro , Nambara Sho , Saito Tomoko , Shinden Yoshiaki , Iguchi Tomohiro , Eguchi Hidetoshi , Ito Shuhei , Terashima Kotaro , Sakamoto Katsumi , Hirakawa Masakazu , Honda Hiroshi , Mimori Koshi
Published: March 2023

Supplementary Materials and Methods, and Legends for Supplementary Figures.
Supplementary Figure S3 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
Authors: Hirata Hidenari , Sugimachi Keishi , Komatsu Hisateru , Ueda Masami , Masuda Takaaki , Uchi Ryutaro , Sakimura Shotaro , Nambara Sho , Saito Tomoko , Shinden Yoshiaki , Iguchi Tomohiro , Eguchi Hidetoshi , Ito Shuhei , Terashima Kotaro , Sakamoto Katsumi , Hirakawa Masakazu , Honda Hiroshi , Mimori Koshi
Published: March 2023

The expression levels of genes specific to gluconeogenesis in HCC cases.
Supplemental Table S1 from JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis
Authors: Li Na , Dhar Shilpa S. , Chen Tsai-Yu , Kan Pu-Yeh , Wei Yongkun , Kim Jae-Hwan , Chan Chia-Hsin , Lin Hui-Kuan , Hung Mien-Chie , Lee Min Gyu
Published: March 2023

RT-PCR Primer Sequences.
Supplementary Figure S1 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
Authors: Hirata Hidenari , Sugimachi Keishi , Komatsu Hisateru , Ueda Masami , Masuda Takaaki , Uchi Ryutaro , Sakimura Shotaro , Nambara Sho , Saito Tomoko , Shinden Yoshiaki , Iguchi Tomohiro , Eguchi Hidetoshi , Ito Shuhei , Terashima Kotaro , Sakamoto Katsumi , Hirakawa Masakazu , Honda Hiroshi , Mimori Koshi
Published: March 2023

Isotopomer distribution analysis using [U-13C]glucose in HuH7 cells with or without ectopic FBP1 expression.
Supplemental Figures S1-S5 from JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis
Authors: Li Na , Dhar Shilpa S. , Chen Tsai-Yu , Kan Pu-Yeh , Wei Yongkun , Kim Jae-Hwan , Chan Chia-Hsin , Lin Hui-Kuan , Hung Mien-Chie , Lee Min Gyu
Published: March 2023

Analysis of JARID1A-D mRNA levels showed that JARID1D knockdown had insignificant or weak effects on expression levels of JARID1A-C (S1); Gene ontology analysis for genes down-regulated in JARID1D-depleted cells (S2); Heatmap for H3K4me3 ChIP-Seq signals of all the gene-regulatory regions spanning âˆ’ 2kb to +2kb suggested that many H3K4me3 signals were slightly increased by JARID1D knockdown. (S3); Of JARID1A-1D, only JARID1D mRNA levels were downregulated in metastasis tumors compared to primary tumors (S4); JARID1D mRNA levels were not correlated with MMP2 (S5).
Legends for Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
Authors: Chartier Cecile , Raval Janak , Axelrod Fumiko , Bond Chris , Cain Jennifer , Dee-Hoskins Cristina , Ma Shirley , Fischer Marcus M. , Shah Jalpa , Wei Jie , Ji May , Lam Andrew , Stroud Michelle , Yen Wan-Ching , Yeung Pete , Cancilla Belinda , O'Young Gilbert , Wang Min , Kapoun Ann M. , Lewicki John , Hoey Timothy , Gurney Austin
Published: March 2023

Supplemental figure legends also include brief methods where appropriate.
Supplementary Figure S1 from Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype
Authors: Li Ling , Li Chao , Wang Shaoxin , Wang Zhaohui , Jiang Jian , Wang Wei , Li Xiaoxia , Chen Jin , Liu Kun , Li Chunhua , Zhu Guiquan
Published: March 2023

CD63 immunoblotting of exosomes isolated from normoxic and hypoxic media respectively.
Supplementary Figure Legends from Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype
Authors: Li Ling , Li Chao , Wang Shaoxin , Wang Zhaohui , Jiang Jian , Wang Wei , Li Xiaoxia , Chen Jin , Liu Kun , Li Chunhua , Zhu Guiquan
Published: March 2023

Legend for Supplementary Figures S1-S4.
Supplementary Figure S5 from Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis
Authors: Ye Long-Yun , Chen Wei , Bai Xue-Li , Xu Xing-Yuan , Zhang Qi , Xia Xue-Feng , Sun Xu , Li Guo-Gang , Hu Qi-Da , Fu Qi-Han , Liang Ting-Bo
Published: March 2023

CCL20 expression is not associated with IDO expression in the normal liver and tumor without PVTT groups.
Supplementary Materials and Methods from Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α
Authors: Schönenberger Désirée , Harlander Sabine , Rajski Michal , Jacobs Robert A. , Lundby Anne-Kristine , Adlesic Mojca , Hejhal Tomas , Wild Peter J. , Lundby Carsten , Frew Ian J.
Published: March 2023

Additional information related to antibodies, oligonucleotides, metabolic assays and respirometry.
Supplementary Table 7 from Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Authors: Gajadhar Aaron S. , Johnson Hannah , Slebos Robbert J.C. , Shaddox Kent , Wiles Kerry , Washington Mary Kay , Herline Alan J. , Levine Douglas A. , Liebler Daniel C. , White Forest M.
Published: March 2023

Supplementary Table 7. Ischemia regulated pTyr sites in {greater than or equal to} 3 patients
Supplementary Table 6 from Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Authors: Gajadhar Aaron S. , Johnson Hannah , Slebos Robbert J.C. , Shaddox Kent , Wiles Kerry , Washington Mary Kay , Herline Alan J. , Levine Douglas A. , Liebler Daniel C. , White Forest M.
Published: March 2023

Supplementary Table 6. Colon tumor pTyr and protein expression groups
Table S4 from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: March 2023

Sequence of the primers used for PCR.
Supplementary Table 5 from Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Authors: Gajadhar Aaron S. , Johnson Hannah , Slebos Robbert J.C. , Shaddox Kent , Wiles Kerry , Washington Mary Kay , Herline Alan J. , Levine Douglas A. , Liebler Daniel C. , White Forest M.
Published: March 2023

Supplementary Table 5. Summary of colon tumor iTRAQ LC-MS/MS protein expession analysis
Table S3 from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: March 2023

Short interfering RNA (siRNA) sequences used in this study.
Figure S9: Loss of RhoB activity increases YAP nuclear localization. from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: March 2023

HBEC-3 cells were transiently transfected with siNeg or siRASSF1A-1 in combination or not with siRhoB A) The invasion capacity was assessed using a BioCoat Matrigel Invasion Chamber. The relative invasion was normalized to that of the cells transfected with siNeg. B) Quantification of nuclear localization of Yap by immunofluorescence and confocal microscopy. The cells stained by Yap primary antibody (Green) followed by Alexa488 conjugated secondary antibody along with DAPI for DNA (Blue). Scale bar represents 50 µm. For all of the histograms, error bars indicate the standard error of the mean (SEM) of at least three independent experiments. *p<0.05, **p<0.01 and ***p<0.001, using an ANOVA test followed by Dunnett's test.
Methods and Supplementary Figures 1-9 from Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Authors: Gajadhar Aaron S. , Johnson Hannah , Slebos Robbert J.C. , Shaddox Kent , Wiles Kerry , Washington Mary Kay , Herline Alan J. , Levine Douglas A. , Liebler Daniel C. , White Forest M.
Published: March 2023

Methods and Supplementary Figures 1-9. Supplementary Figure 1: Histopathology images of tumors used in ischemia time-course and spatial heterogeneity experiments. Supplementary Figure 2: Schematic overview of ovarian tumor ischemia time-course experiment. Supplementary Figure 3: Distinct inter-patient ischemia regulated temporal dynamics are observed. Supplementary Figure 4: Similar ischemia response temporal patterns are observed across ovarian tumors. Supplementary Figure 5: Schematic overview of the colon tumor spatial heterogeneity and ischemia time-course experiment. Supplementary Figure 6: Spatial phosphorylation heterogeneity in colons tumors cannot be attributed solely to technical measurement error. Supplementary Figure 7: Weak correlations and minimal shared covariance between spatially proximal colon tumor samples. Supplementary Figure 8: Schematic overview of the colon tumor protein expression profiling experiment. Supplementary Figure 9: Delayed freezing of tumors affects pTyr sites involved in numerous pathways and processes.
Supplementary Figures 1 through 7, Supplementary Tables 1 through 9 from Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
Authors: Hubbard Gretchen K. , Mutton Laura N. , Khalili May , McMullin Ryan P. , Hicks Jessica L. , Bianchi-Frias Daniella , Horn Lucas A. , Kulac Ibrahim , Moubarek Michael S. , Nelson Peter S. , Yegnasubramanian Srinivasan , De Marzo Angelo M. , Bieberich Charles J.
Published: March 2023

Supplementary Figure 1 Morphology of PIN in B13-MYC mice. Supplementary Figure 2 Phenotypic analysis of PIN in a B13-MYC mouse (ventral lobe, 52 weeks old). Supplementary Figure 3 Additional phenotypic analysis of B-MYC/Pten mouse PIN (anterior lobe, 8 weeks). Supplementary Figure 4 Invasive adenocarcinoma lesion in a 14 week old B-MYC/Pten animal. Supplementary Figure 5 Chromogranin (a) staining in a primary tumor and Foxa2 (b) staining in a lymph node metastasis from a 24 week-old B-MYC/Pten animal shows focal scattered tumor cells staining positively (arrows). Supplementary Figure 6 Morphological features of castrated B-MYC/Pten animals. Supplementary Figure 7. Genes within regions of copy number gains and losses are enriched in specific gene ontology (GO) gene sets. Supplementary Table 1. Prostate Phenotype in B-MYC/PtenFl/Fl mice and wild type (FVB/N) mice. Supplementary Table 2. Metastatic Spread in B-MYC/PtenFl/Fl mice and wild type (FVB/N) mice. Supplementary Table 3. Prostate Phenotype in B-MYC/PtenFl/+ mice and wild type mice. Supplementary Table 4. Effects of androgen withdrawal/castration in B-MYC/PtenFl/Fl mice and wild type (FVB/N) mice. Supplementary Table 5. Metastatic Spread in B-MYC/PtenFl/Fl mice after androgen withdrawal. Supplementary Table 6. Somatic copy number gains and losses in each sample. Supplementary Table 7. Regions of Copy Number alterations in each sample. Supplementary Table 8. Regions with recurrent gains and losses in at least two mice. Supplementary Table 9. Regions of high copy number gain and low copy number loss in any tumor specimen.
Figure S2: Depletion of RASSF1A alone or with RASSF1C results in disappearance of tight junctions and decrease of adherens junction, replaced by diffuse adherent junctions. from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: March 2023

Three independent air-liquid cultures, each requiring 21 days of growth before fixation and observation, were analyzed. For each culture, 2 slides through the porous membrane and the cells have been performed, those slides being processed at the center of the membrane to avoid artifacts linked to a peripheral location. For siNeg condition (only one stratum of cells) 50 to 70 cells were observed, whereas for siRASSF1A conditions, 50 to 250 cells (several strata of cells) were analyzed. For all of the histograms, error bars indicate the standard error of the mean (SEM) of at least three independent experiments. *p<0.05, **p<0.01, using an ANOVA test followed by Dunnett's test.
Supplemental Figure S4 from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells
Authors: Giraud Julie , Failla Laura M. , Pascussi Jean-Marc , Lagerqvist Ebba L. , Ollier Jérémy , Finetti Pascal , Bertucci François , Ya Chu , Gasmi Imène , Bourgaux Jean-François , Prudhomme Michel , Mazard Thibault , Ait-Arsa Imade , Houhou Leila , Birnbaum Daniel , Pélegrin André , Vincent Charles , Ryall James G. , Joubert Dominique , Pannequin Julie , Hollande Frédéric
Published: March 2023

shRNA-mediated down regulation of progastrin in vitro and in vivo.
Supplemental Figure S3 from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells
Authors: Giraud Julie , Failla Laura M. , Pascussi Jean-Marc , Lagerqvist Ebba L. , Ollier Jérémy , Finetti Pascal , Bertucci François , Ya Chu , Gasmi Imène , Bourgaux Jean-François , Prudhomme Michel , Mazard Thibault , Ait-Arsa Imade , Houhou Leila , Birnbaum Daniel , Pélegrin André , Vincent Charles , Ryall James G. , Joubert Dominique , Pannequin Julie , Hollande Frédéric
Published: March 2023

Progastrin regulates the self-renewal of ALDHhigh colorectal CSCs.
Supplementary Table 2 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
Authors: Shono Yusuke , Tuckett Andrea Z. , Liou Hsiou-Chi , Doubrovina Ekaterina , Derenzini Enrico , Ouk Samedy , Tsai Jennifer J. , Smith Odette M. , Levy Emily R. , Kreines Fabiana M. , Ziegler Carly G.K. , Scallion Mary I. , Doubrovin Mikhail , Heller Glenn , Younes Anas , O'Reilly Richard J. , van den Brink Marcel R.M. , Zakrzewski Johannes L.
Published: March 2023

ROS/RNS induction by IT-­901 treatement in normal tissues.
Supplemental Figure S2 from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells
Authors: Giraud Julie , Failla Laura M. , Pascussi Jean-Marc , Lagerqvist Ebba L. , Ollier Jérémy , Finetti Pascal , Bertucci François , Ya Chu , Gasmi Imène , Bourgaux Jean-François , Prudhomme Michel , Mazard Thibault , Ait-Arsa Imade , Houhou Leila , Birnbaum Daniel , Pélegrin André , Vincent Charles , Ryall James G. , Joubert Dominique , Pannequin Julie , Hollande Frédéric
Published: March 2023

Progastrin inhibition decreases colonosphere incidence, CSC frequency and ALDHhigh cell proportion in vitro.
Supplemental Figure S1 from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells
Authors: Giraud Julie , Failla Laura M. , Pascussi Jean-Marc , Lagerqvist Ebba L. , Ollier Jérémy , Finetti Pascal , Bertucci François , Ya Chu , Gasmi Imène , Bourgaux Jean-François , Prudhomme Michel , Mazard Thibault , Ait-Arsa Imade , Houhou Leila , Birnbaum Daniel , Pélegrin André , Vincent Charles , Ryall James G. , Joubert Dominique , Pannequin Julie , Hollande Frédéric
Published: March 2023

ALDHhigh CRC cells display CSC characteristics and elevated progastrin expression.
Supplementary Figure 8 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
Authors: Shono Yusuke , Tuckett Andrea Z. , Liou Hsiou-Chi , Doubrovina Ekaterina , Derenzini Enrico , Ouk Samedy , Tsai Jennifer J. , Smith Odette M. , Levy Emily R. , Kreines Fabiana M. , Ziegler Carly G.K. , Scallion Mary I. , Doubrovin Mikhail , Heller Glenn , Younes Anas , O'Reilly Richard J. , van den Brink Marcel R.M. , Zakrzewski Johannes L.
Published: March 2023

c-Rel is constitutively active in a wide range of human lymphoma types.
Supplementary Figure 7 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
Authors: Shono Yusuke , Tuckett Andrea Z. , Liou Hsiou-Chi , Doubrovina Ekaterina , Derenzini Enrico , Ouk Samedy , Tsai Jennifer J. , Smith Odette M. , Levy Emily R. , Kreines Fabiana M. , Ziegler Carly G.K. , Scallion Mary I. , Doubrovin Mikhail , Heller Glenn , Younes Anas , O'Reilly Richard J. , van den Brink Marcel R.M. , Zakrzewski Johannes L.
Published: March 2023

Effects of IT-901 on lymphocyte subsets in the spleen.
Supplemental Table 1 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
Authors: Ohashi Yoshimi , Okamura Mutsumi , Hirosawa Asaka , Tamaki Naomi , Akatsuka Akinobu , Wu Kuo-Ming , Choi Hyeong-Wook , Yoshimatsu Kentaro , Shiina Isamu , Yamori Takao , Dan Shingo
Published: March 2023

The antibodies used in this study.
Supplemental Materials and Methods from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
Authors: Ohashi Yoshimi , Okamura Mutsumi , Hirosawa Asaka , Tamaki Naomi , Akatsuka Akinobu , Wu Kuo-Ming , Choi Hyeong-Wook , Yoshimatsu Kentaro , Shiina Isamu , Yamori Takao , Dan Shingo
Published: March 2023

Supplemental Materials and Methods for "Authentication of cell lines"
Supplementary Figure 3 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
Authors: Shono Yusuke , Tuckett Andrea Z. , Liou Hsiou-Chi , Doubrovina Ekaterina , Derenzini Enrico , Ouk Samedy , Tsai Jennifer J. , Smith Odette M. , Levy Emily R. , Kreines Fabiana M. , Ziegler Carly G.K. , Scallion Mary I. , Doubrovin Mikhail , Heller Glenn , Younes Anas , O'Reilly Richard J. , van den Brink Marcel R.M. , Zakrzewski Johannes L.
Published: March 2023

IT-901 has a superior pharmacokinetic profile.
Supplementary Figure 2 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
Authors: Shono Yusuke , Tuckett Andrea Z. , Liou Hsiou-Chi , Doubrovina Ekaterina , Derenzini Enrico , Ouk Samedy , Tsai Jennifer J. , Smith Odette M. , Levy Emily R. , Kreines Fabiana M. , Ziegler Carly G.K. , Scallion Mary I. , Doubrovin Mikhail , Heller Glenn , Younes Anas , O'Reilly Richard J. , van den Brink Marcel R.M. , Zakrzewski Johannes L.
Published: March 2023

IT-901 is a more potent NF-κB inhibitor than IT-603.
Supplemental Figure 2 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
Authors: Ohashi Yoshimi , Okamura Mutsumi , Hirosawa Asaka , Tamaki Naomi , Akatsuka Akinobu , Wu Kuo-Ming , Choi Hyeong-Wook , Yoshimatsu Kentaro , Shiina Isamu , Yamori Takao , Dan Shingo
Published: March 2023

Effect of M-COPA on cell surface expression and phosphorylation status of HER3 in MKN-45 cells.
Supplementary Figure 10 from Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
Authors: Shono Yusuke , Tuckett Andrea Z. , Liou Hsiou-Chi , Doubrovina Ekaterina , Derenzini Enrico , Ouk Samedy , Tsai Jennifer J. , Smith Odette M. , Levy Emily R. , Kreines Fabiana M. , Ziegler Carly G.K. , Scallion Mary I. , Doubrovin Mikhail , Heller Glenn , Younes Anas , O'Reilly Richard J. , van den Brink Marcel R.M. , Zakrzewski Johannes L.
Published: March 2023

Several NF-κB subunits are constitutively active in activated B-like DLBCL cell lines.
Supplementary Table S6 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
Authors: Dolai Sibasish , Sia Keith C.S. , Robbins Alissa K. , Zhong Ling , Heatley Sue L. , Vincent Tiffaney L. , Hochgräfe Falko , Sutton Rosemary , Kurmasheva Raushan T. , Revesz Tamas , White Deborah L. , Houghton Peter J. , Smith Malcolm A. , Teachey David T. , Daly Roger J. , Raftery Mark J. , Lock Richard B.
Published: March 2023

Average intensities of all light (PDX) and heavy (SILAC) Class I phosphosites p(STY) identified in 16 PDXs with Tyrosine kinase downstream targets highlighted in yellow.
Supplementary Table S5 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
Authors: Dolai Sibasish , Sia Keith C.S. , Robbins Alissa K. , Zhong Ling , Heatley Sue L. , Vincent Tiffaney L. , Hochgräfe Falko , Sutton Rosemary , Kurmasheva Raushan T. , Revesz Tamas , White Deborah L. , Houghton Peter J. , Smith Malcolm A. , Teachey David T. , Daly Roger J. , Raftery Mark J. , Lock Richard B.
Published: March 2023

Average normalized ratio of phosphorylated tyrosine (pY) sites of tyrosine kinases identified in 16 PDXs
Supplementary Table S2 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
Authors: Dolai Sibasish , Sia Keith C.S. , Robbins Alissa K. , Zhong Ling , Heatley Sue L. , Vincent Tiffaney L. , Hochgräfe Falko , Sutton Rosemary , Kurmasheva Raushan T. , Revesz Tamas , White Deborah L. , Houghton Peter J. , Smith Malcolm A. , Teachey David T. , Daly Roger J. , Raftery Mark J. , Lock Richard B.
Published: March 2023

Class I phosphotyrosine (pY) sites of the "Tyrosine Kinases" enriched either in T-ALL (ALL-8, ALL-31) and B-ALL (ALL-17, ALL-19)
Supplementary Table S1 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
Authors: Dolai Sibasish , Sia Keith C.S. , Robbins Alissa K. , Zhong Ling , Heatley Sue L. , Vincent Tiffaney L. , Hochgräfe Falko , Sutton Rosemary , Kurmasheva Raushan T. , Revesz Tamas , White Deborah L. , Houghton Peter J. , Smith Malcolm A. , Teachey David T. , Daly Roger J. , Raftery Mark J. , Lock Richard B.
Published: March 2023

Class I phosphosites (pSTY) identified in T-ALL (ALL-8, ALL-31) and B-ALL (ALL-17, ALL-19)
Supplemental Figures S1-S4 from Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling
Authors: Yeo Syn Kok , Wen Jian , Chen Song , Guan Jun-Lin
Published: March 2023

Gating strategy for analysis and isolation of CSC populations (S1); Tumors that arise from transplanted sorted populations recapitulate features of parental tumors (S2); Tumors that arise from transplanted sorted populations display Stat3 and Smad2 activation (S3); Inhibition of autophagy after FIP200 deletion (S4).
Supplementary Table 1 from Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Authors: Dou Qianhui , Chen Hai-Ning , Wang Kui , Yuan Kefei , Lei Yunlong , Li Kai , Lan Jiang , Chen Yan , Huang Zhao , Xie Na , Zhang Lu , Xiang Rong , Nice Edouard C. , Wei Yuquan , Huang Canhua
Published: March 2023

Supplementary Table 1
Supplemental Methods from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
Authors: Choi Dongwon , Ramu Swapnika , Park Eunkyung , Jung Eunson , Yang Sara , Jung Wonhyeuk , Choi Inho , Lee Sunju , Kim Kyu Eui , Seong Young Jin , Hong Mingu , Daghlian George , Kim Daniel , Shin Eugene , Seo Jung In , Khatchadourian Vicken , Zou Mengchen , Li Wei , De Filippo Roger , Kokorowski Paul , Chang Andy , Kim Steve , Bertoni Ana , Furlanetto Tania Weber , Shin Sung , Li Meng , Chen Yibu , Wong Alex , Koh Chester , Geliebter Jan , Hong Young-Kwon
Published: March 2023

Supplemental Methods
Supplementary Figure S1-2 from Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Authors: Dou Qianhui , Chen Hai-Ning , Wang Kui , Yuan Kefei , Lei Yunlong , Li Kai , Lan Jiang , Chen Yan , Huang Zhao , Xie Na , Zhang Lu , Xiang Rong , Nice Edouard C. , Wei Yuquan , Huang Canhua
Published: March 2023

Supplementary Figure S1-2
Supplemental Figures from Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
Authors: Morrison Joly Meghan , Hicks Donna J. , Jones Bayley , Sanchez Violeta , Estrada Monica Valeria , Young Christian , Williams Michelle , Rexer Brent N. , Sarbassov Dos D. , Muller William J. , Brantley-Sieders Dana , Cook Rebecca S.
Published: March 2023

Supplemental Figure S1. Kaplan meier analysis and oncoprint mapping of Luminal A/B (A) and Basal-like (B) TCGA-curated breast cancers, showing the tumors in each set with upregulation of Akt1/2/3 mRNA (red boxes) or phospho-S473 (black arrows), and the survival of these patients (red Kaplan-Meier line) versus other patients (blue Kaplan-Meier line). Log-rank test shows insignificance. Supplemental Figure S2. Rictor expression in human breast cancer. Supplemental Figure S3. Oncoprint of TCGA-curated invasive breast cancers (TCGA, Cell 2015, N = 971) assessed for RICTOR genomic alterations. Analysis shows 8% of cases (76/971) with gene amplification, overexpression, missense mutation, or deep deletion. Supplemental Figure S4. Rictor mRNA expression was measured by qRT-PCR of total RNA from mammary glands harvested from virgin female 12-week old mice. Supplemental Figure S5. Genetic ablation of Rictor decreases growth and survival of HER2-positive breast cancer cells. Supplemental Figure S6. A. Cells were cultured 6 hours with FITC-labeled Annexin V, then imaged. B. MCF10-HER2 cells (parental, Rictor, SFN, and Rictor ZFN + exogenous expression of myc-tagged Rictor) were cultured 6 h with An-nexin V-FITC. C. The percentage of cells in panel B that were labeled with Annexin V-FITC was quantitated. Averages (midlines) Â± S.D. were assessed for significance using StudentÂ€™s two-tailed unpaired T-test. Supplemental Figure S7. Rictor-mediated Akt activity is necessary and sufficient for breast cancer cell survival. Supplemental Figure S8. Cells were treated with lapatinib for the time course indicated. Total cell RNA was used for qRT-PCR to measure relative RPTOR mRNA expression. Supplemental Figure S9. Cells were cultured 7 days in 10% serum plus lapatinib (1 Î¼M) or PP242 (1 Î¼M) or the combination of lapatinib + PP242. Cells were stained with crystal violet. Crystal violet fluorescence was scanned using the odyssey. Representative images are shown. Supplemental Figure S10. Loss of Rictor/mTORC2 sensitizes parental and resistant cells to lapatinib in vitro Supplemental Figure S11. Cells were treated 6h with PP242 (1Î¼M) Â± lapatinib (1Î¼M) and assessed by luminescent caspase-3/7 assay.
Supplemental Table S1 from Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer
Authors: Lee Yu-Chen , Lin Song-Chang , Yu Guoyu , Cheng Chien-Jui , Liu Bin , Liu Hsuan-Chen , Hawke David H. , Parikh Nila U. , Varkaris Andreas , Corn Paul , Logothetis Christopher , Satcher Robert L. , Yu-Lee Li-Yuan , Gallick Gary E. , Lin Sue-Hwa
Published: March 2023

Primers used in PCR.
Supplemental Figure S6 from Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer
Authors: Lee Yu-Chen , Lin Song-Chang , Yu Guoyu , Cheng Chien-Jui , Liu Bin , Liu Hsuan-Chen , Hawke David H. , Parikh Nila U. , Varkaris Andreas , Corn Paul , Logothetis Christopher , Satcher Robert L. , Yu-Lee Li-Yuan , Gallick Gary E. , Lin Sue-Hwa
Published: March 2023

Combination of cabozantinib with PF-562271 delays tumor recurrence after treatments cessation.
Supplemtary Table 1 from Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
Authors: Tohme Samer , Yazdani Hamza O. , Al-Khafaji Ahmed B. , Chidi Alexis P. , Loughran Patricia , Mowen Kerri , Wang Yanming , Simmons Richard L. , Huang Hai , Tsung Allan
Published: March 2023

Supplementary Table 1. Baseline characteristics of patients undergoing hepatectomy.
Supplemtary Figure 2 from Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
Authors: Tohme Samer , Yazdani Hamza O. , Al-Khafaji Ahmed B. , Chidi Alexis P. , Loughran Patricia , Mowen Kerri , Wang Yanming , Simmons Richard L. , Huang Hai , Tsung Allan
Published: March 2023

Supplementary Figure 2 contains results showing 1) increased hypoxia and NET formation in human resected metastatic colorectal cancer tumors. 2) Protumorigenic effects of NETs in Hep1-6 cancer cell lines. 3)Increased HMGB1 levels in patients after major liver resection.
Supplemetary Methods from Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
Authors: Tohme Samer , Yazdani Hamza O. , Al-Khafaji Ahmed B. , Chidi Alexis P. , Loughran Patricia , Mowen Kerri , Wang Yanming , Simmons Richard L. , Huang Hai , Tsung Allan
Published: March 2023

Supplementary methods
Supplementary Legends from Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
Authors: Tohme Samer , Yazdani Hamza O. , Al-Khafaji Ahmed B. , Chidi Alexis P. , Loughran Patricia , Mowen Kerri , Wang Yanming , Simmons Richard L. , Huang Hai , Tsung Allan
Published: March 2023

Legends for Supplementary Figures and Table
Supplementary Figure 3 from Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
Authors: Tohme Samer , Yazdani Hamza O. , Al-Khafaji Ahmed B. , Chidi Alexis P. , Loughran Patricia , Mowen Kerri , Wang Yanming , Simmons Richard L. , Huang Hai , Tsung Allan
Published: March 2023

Supplementary Figure 3. Schematic diagrams of the proposed role of NETs in the progression of metastatic disease after surgical stress.
Supplemental Figure S1 from Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer
Authors: Lee Yu-Chen , Lin Song-Chang , Yu Guoyu , Cheng Chien-Jui , Liu Bin , Liu Hsuan-Chen , Hawke David H. , Parikh Nila U. , Varkaris Andreas , Corn Paul , Logothetis Christopher , Satcher Robert L. , Yu-Lee Li-Yuan , Gallick Gary E. , Lin Sue-Hwa
Published: March 2023

Immunostaining of control PCa-118b tumors for the expression of AE1/AE3 antigen and osteocalcin with DAPI counterstain.
Supplementary Figures 1-3 from GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
Authors: Gupta Kalpana , Stefan Tammy , Ignatz-Hoover James , Moreton Stephen , Parizher Gary , Saunthararajah Yogen , Wald David N.
Published: March 2023

Western blot control for GSK3β knockdown, rrimer sequences for real-time PCR and FAB subtype and known genetic information on AML cells
Legend for Supplementary Files from Identification of DNA Methylation–Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma
Authors: Becket Elinne , Chopra Sameer , Duymich Christopher E. , Lin Justin J. , You Jueng Soo , Pandiyan Kurinji , Nichols Peter W. , Siegmund Kimberly D. , Charlet Jessica , Weisenberger Daniel J. , Jones Peter A. , Liang Gangning
Published: March 2023

Legend and description of Supplementary Figures 1-8
Supplementary Figure Legends from GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
Authors: Gupta Kalpana , Stefan Tammy , Ignatz-Hoover James , Moreton Stephen , Parizher Gary , Saunthararajah Yogen , Wald David N.
Published: March 2023

Supplementary Figure Legends
Supplementary Figure 5 from GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
Authors: Gupta Kalpana , Stefan Tammy , Ignatz-Hoover James , Moreton Stephen , Parizher Gary , Saunthararajah Yogen , Wald David N.
Published: March 2023

Pathways exhibiting significant changes in activation after 1,25D and GSK3 inhibitor treatment
supplemental figure 6 from Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells
Authors: Shi Yijiang , Daniels-Wells Tracy R. , Frost Patrick , Lee Jihye , Finn Richard S. , Bardeleben Carolyne , Penichet Manuel L. , Jung Michael E. , Gera Joseph , Lichtenstein Alan
Published: March 2023

SUPPL FIG 6: PBLs obtained from 3 normal individuals and incubated with increasing concentrations of NSC 126405 for 72 hrs. Surviving viable cells enumerated. Data are % of control (no drug B), mean+/-SD, n=3.
supplemental figure 5 from Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells
Authors: Shi Yijiang , Daniels-Wells Tracy R. , Frost Patrick , Lee Jihye , Finn Richard S. , Bardeleben Carolyne , Penichet Manuel L. , Jung Michael E. , Gera Joseph , Lichtenstein Alan
Published: March 2023

SUPPL fig 5: Growth of individual tumors from mice injected with vehicle (control) or drug at 10 or 20 mg/kg
supplemental figure 4 from Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells
Authors: Shi Yijiang , Daniels-Wells Tracy R. , Frost Patrick , Lee Jihye , Finn Richard S. , Bardeleben Carolyne , Penichet Manuel L. , Jung Michael E. , Gera Joseph , Lichtenstein Alan
Published: March 2023

SUPPL FIG 4: A) 8226 cells treated +/- NSC 126405 for 18 hrs followed by immunoblot assays. Fold BIM increase is determined by densitometry, mean of 3 experiments; B) Control (shSCR) or RAPTOR-silenced 8226 cells (shRAPTOR) treated +/- NSC 126405 for 18 hrs followed by immunoblot assays. Fold BIM increase is mean of 3 experiments.
Supplemental Material from Detection of Pancreatic Cancer–Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance
Authors: Winnard Paul T. , Bharti Santosh K. , Penet Marie-France , Marik Radharani , Mironchik Yelena , Wildes Flonne , Maitra Anirban , Bhujwalla Zaver M.
Published: March 2023

Title Page Supplemental Material and Methods Supplemental Results Supplemental Reference Supplemental Figure Legends
Supplemental Figure S3 from Detection of Pancreatic Cancer–Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance
Authors: Winnard Paul T. , Bharti Santosh K. , Penet Marie-France , Marik Radharani , Mironchik Yelena , Wildes Flonne , Maitra Anirban , Bhujwalla Zaver M.
Published: March 2023

Supplemental Figure S3. Induction of tdT fluorescence occurred at an early time during tumor growth and was dependent on the tumor type in the s.c. model of pancreatic cancer.
Supplemental Figure S2 from Detection of Pancreatic Cancer–Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance
Authors: Winnard Paul T. , Bharti Santosh K. , Penet Marie-France , Marik Radharani , Mironchik Yelena , Wildes Flonne , Maitra Anirban , Bhujwalla Zaver M.
Published: March 2023

Supplemental Figure S2. Weight loss and tdT fluorescence induction is dependent on tumor type in an orthotopic model of pancreatic cancer.
supplemental figure 1 from Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells
Authors: Shi Yijiang , Daniels-Wells Tracy R. , Frost Patrick , Lee Jihye , Finn Richard S. , Bardeleben Carolyne , Penichet Manuel L. , Jung Michael E. , Gera Joseph , Lichtenstein Alan
Published: March 2023

SUPPL FIG 1: A) Only yeast transfected with both FAT domain/GAL4DBD +DEPTOR/GAL4 AD show growth on selective media. Yeast transfected w/ either construct alone can not grow. Two separate transformations shown. B) Four initial 'hits' from drug screen